Profile
Sharon Morani currently works at Vigil Neuroscience, Inc., as Senior Director-Facilities & Operations from 2024.
Ms. Morani also formerly worked at Atlas Venture Advisors, Inc., as Director-Portfolio Operations from 2019 to 2022 and WebLayers, Inc., as Director from 2008 to 2009.
Ms. Morani received her undergraduate degree from Salem State University.
Sharon Morani active positions
| Companies | Position | Start |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Chief Operating Officer | 01/06/2022 |
Former positions of Sharon Morani
| Companies | Position | End |
|---|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2022 |
WebLayers, Inc.
WebLayers, Inc. Packaged SoftwareTechnology Services Develops automated software testing solutions | Private Equity Investor | 01/02/2009 |
Education of Sharon Morani
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Salem State University
Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WebLayers, Inc.
WebLayers, Inc. Packaged SoftwareTechnology Services Develops automated software testing solutions | Technology Services |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Sharon Morani
















